White label ELPA - ClinicalTrials.eu

Study on Durvalumab, Paclitaxel, Carboplatin, and Olaparib for Patients with Advanced or Recurrent Endometrial Cancer

Not recruiting

3 1 1
Investigated Drugs:
+2
Study Comparing Pemigatinib and Gemcitabine Plus Cisplatin for First-Line Treatment in Patients with Unresectable or Metastatic Cholangiocarcinoma with FGFR2 Rearrangement

Not recruiting

3 1 1 1
Investigated Diseases:
- Cholangiocarcinoma
Investigated Drugs:
+2
Study on the Long-Term Safety and Effectiveness of Ozanimod for Adults with Moderate to Severe Ulcerative Colitis

Not recruiting

3 1 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Ozanimod
+1
Study of Spartalizumab and Drug Combination for Patients with Metastatic Anal Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Anal squamous cell carcinoma
Investigated Drugs:
Study on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3

Not recruiting

3 1
Investigated Drugs:
- Lanifibranor
+5
Study on Tafasitamab with Gemcitabine, Oxaliplatin, and Rituximab for Patients with Aggressive B-cell Lymphoma

Not recruiting

2 1 1 1
Investigated Drugs:
Study of Rocatinlimab compared to Placebo to help adults with Moderate to Severe Asthma

Not recruiting

2 1
Investigated Diseases:
- Asthma
Investigated Drugs:
- Rocatinlimab
Study on Short vs. 12-Month Use of Prasugrel and Aspirin for Patients with Acute Coronary Syndromes Undergoing Stent Procedures

Not recruiting

3 1 1 1
Investigated Diseases:
- Acute coronary syndrome
Investigated Drugs:
- Acetylsalicylic Acid
- Prasugrel
Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

Not recruiting

2 1
Investigated Diseases:
- Pulmonary fibrosis
- Idiopathic pulmonary fibrosis
Investigated Drugs:
- Bi 1839100
+9
Study of amlitelimab injection compared to placebo for adults with severe alopecia areata (hair loss)

Not recruiting

2 1
Investigated Diseases:
- Alopecia areata
Investigated Drugs:
- Amlitelimab
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies